dihexa clinical trials status trial Dihexa shows neurotrophic activity exceeding BDNF in preclinical studies copper peptide ghk cu serum – dihexa studies dihexa human clinical

Approval status: Unlike most peptides on this site, tesamorelin is FDA-approved (brand Egrifta / Egrifta SV ) but only for one specific indication: reducing excess abdominal fat in HIV-associated lipodystrophy

Thanks I might try that, think I'll sound a bit silly if I ring them and not sure they'd do anything but I've never had this before and been having injections for a few years now so might give the pharmacy a try If you think it's urgent, you could ring NHS 111

The authors concluded that intra-articular BPC 157 injection could be a promising treatment option for patients with various types of knee pain, including osteoarthritis, patellar tendonitis, and meniscal tears

do not self-initiate Dosing data for BPC-157 in humans is limited